Dedicated to improving the health and well-being of people around the world.
We drive innovative treatments, science, and technology to address patient needs in the critical areas of psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy.
Discovering Sumitomo Pharma America (SMPA)
Innovation growth engine
Drug discovery, development, and commercialization must become faster and more efficient to address humanity’s health needs. SMPA embodies the bold promise of combining technology and life-sciences expertise to measurably improve patient outcomes.
Diverse pipeline
Our preclinical and clinical programs span numerous modalities and indications where patient needs remain high or unmet.
Fueling breakthroughs
Delivering patient-first solutions sooner through a technology-driven approach.